Biomedical subjects

D Pöthig

Publications and source records attributed to D Pöthig.

22 records · Page 2Linked to original sources

PubMedDate not supplied

[Sex differences in biologic aging. Results of an experimental study].

The authors report on first experimentally verified findings concerning the sex-specific ageing dynamism of man. The study is based on reference values of biological age which could be gathered by employing a clinical complex technique. This technique is conspicuous for its high precision; the reference-value quality of the model curves likewise satisfying all test theoretical criteria. The reference values of biological age characterize the dynamism of ageing within a randomized population group, i.e. 197 male and 168 female citizens aged between 18 and 75 years who were living in urban Leipzig and mainly employed in the working process. Remarkably enough, there hardly appear to be any differences between the two sexes as far as the rate of ageing is concerned. This causes the authors to emphasize the great importance of sex-differentiated morbidity for an increased mortality among men in the industrialized countries. A genetically predetermined higher rate of ageing among men and a resulting lower life expectancy exclusively contingent on it does not seem to exist. These experimentally obtained results correspond in tendency to epidemiological data.

Adult↗

PubMedDate not supplied

[Giessen test of the aging dynamics of social behavior].

The Giessen-test was applied during gerontological complex investigations to study the biological ages of predominantly professionally engaged Leipzig citizens. Four dimensions of this psycho-diagnostical procedure showed a clear age-characteristic confirming the tendencially known features of psycho-social ageing. The achieved results point again to the fact that the deficit-model of ageing processes is not justified in psycho-social relations, in particular. The experiences of this experimental series claim further that the Giessen Test should be applied with old-age people reserve only because of the methodical problems implied.

Adaptation, Psychological↗

PubMedDate not supplied

[Significance of determining biologic aging for gerontology].

Based upon historical findings in age research the authors state that new, actual hypotheses and models and the experimental examination of which incite re-thinking on the inter-disciplinary role or gerontology. The authors start from the fact that it seems to be possible today - GDR gerontology is capable to essentially support international research activities - to sufficiently precisely determine the biological age(ing) of human beings by the multi-factorial functional diagnostics. The degree of vitality is hereby applied as the criterion of biological age(ing) that considers the asynchronous bio-social dynamics of human ageing during the periods of development, maturity and regression. Gerontology is thereby now capable to define sex differently valid references values ("standard values") for vitality and biological age throughout all the ages. The authors elaborate the idea that the efforts of medical research activities are concentrating on the attempt to improve vitality which has been reduced by illness to an age-adequate level, while sport sciences are trying to increase vitality beyond this level during all the periods of life. From these aspects gerontology wins a new inter-disciplinary status as a scientific-theoretical and operational link between medicine and sport sciences. Both, gerontology and sports medicine in particular will have to make pioneers' works to spread these ideas.

Adolescent↗

PubMedDate not supplied

[The use of Ergocomb in symptoms of cerebrovascular insufficiency].

Using a test design of subjective, clinical and psychometric parameters, Ergocomb was tested, in a double-blind trial, on fifty-five patients with cerebrovascular insufficiency. The test results, which are in agreement with those reported in the literature, show a substantial improvement of various subjective and objective criteria. Therefore, Ergocomb, in the form of swallowable tablets, is considered suitable for application to patients with senile cerebral insufficiency, the recommended dosage being 3 x 1 mg.

Aged↗